Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Evaxion A/S - Sponsored ADR (EVAX) vs Kyntra Bio Inc (KYNB)

Evaxion A/S - Sponsored ADR and Kyntra Bio Inc are both Biotechnology companies. Evaxion A/S - Sponsored ADR and Kyntra Bio Inc are of similar size ($28.3M and $27.2M). Evaxion A/S - Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Kyntra Bio Inc trades at 0.2×. Kyntra Bio Inc has the higher net margin (3,967.8% vs 0.00%) and the higher return on invested capital (0.00% vs −245.8%). Across the 15 metrics below, Evaxion A/S - Sponsored ADR leads on 8 and Kyntra Bio Inc on 7.

Valuation

Metric EVAX KYNB Biotechnology median
P/E n/m 0.15 7.88
P/S 2.31 6.08 11.47
P/B 2.59 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 1.63 18.18 10.73
Earnings yield (29.31%) 652.74% (28.84%)
Free cash flow yield (149.03%) (135.59%) (23.03%)

Profitability

Metric EVAX KYNB Biotechnology median
Gross margin 100.00% 6.28% 65.16%
Operating margin 0.00% (1,089.78%) 0.00%
Net margin 0.00% 3,967.77% 0.00%
Free cash flow margin 0.00% (824.19%) 0.00%
Return on equity (96.10%) (157.83%) (57.72%)
Return on assets (36.20%) 131.26% (49.22%)
Return on invested capital (245.79%) 0.00% 0.00%

Growth

Metric EVAX KYNB Biotechnology median
Revenue growth (TTM) — (37.15%) 5.64%
EPS growth (last fiscal year) 89.85% 478.08% —
Revenue growth, 5-year CAGR — (48.42%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EVAX KYNB Biotechnology median
Debt to equity 0.71 0.00 0.00
Current ratio 5.06 2.69 4.73
Net debt to EBITDA 1.87 1.97 0.96

Dividend

Metric EVAX KYNB Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric EVAX KYNB Biotechnology median
Market cap 27.19m 28.34m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack